V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20211772 | 20128526 | 1.84 | 90.9 | Palliative (P) | null | 2019-03-08 | ECX | 2 | N | ECX | 101589978 |
| 20211779 | 20128527 | 1.54 | 98.6 | Curative (C) | 2019-09-12 | 2019-09-24 | Panitumumab | 02 | null | PANITUMUMAB | 101149212 |
| 20211785 | 20128528 | 1.7 | 88.4 | Palliative (P) | 2017-12-19 | 2018-04-17 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 100153353 |
| 20211786 | 20128529 | 1.7 | 108 | Palliative (P) | 2020-02-09 | 2020-03-01 | ECX | 2 | N | ECX | 101322623 |
| 20211787 | 20128530 | null | 48.2 | Palliative (P) | null | 2019-07-12 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 100497499 |
| 20211788 | 20128531 | 1.75 | 48.6 | Curative (C) | 2018-11-12 | 2018-12-28 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101266274 |
| 20211793 | 20128532 | 1.64 | null | null | 2016-05-13 | 2016-06-01 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 100095164 |
| 20211795 | 20128533 | 1.64 | null | Palliative (P) | 2018-09-05 | 2018-09-12 | ECX | null | N | ECX | 100304561 |
| 20211802 | 20128534 | 1.65 | 95.5 | Neo-adjuvant (N) | 2020-12-13 | 2020-12-24 | null | 99 | N | CARBOPLATIN + ETOPOSIDE | 100423387 |
| 20211809 | 20128536 | 1.81 | 73.2 | null | 2019-02-12 | 2019-04-17 | null | 02 | null | ECX | 100624907 |
| 20211823 | 20128537 | 1.75 | 95.1 | Neo-adjuvant (N) | 2019-01-30 | 2019-02-07 | null | 02 | N | ECX | 100951053 |
| 20211839 | 20128539 | 1.78 | 71.4 | Palliative (P) | 2018-02-28 | 2018-03-06 | Panitumumab | 02 | N | PANITUMUMAB | 101017504 |
| 20211852 | 20128540 | 1.56 | 73 | Neo-adjuvant (N) | null | 2018-04-15 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101774406 |
| 20211854 | 20128541 | 1.96 | 104 | Palliative (P) | 2017-01-10 | 2017-02-03 | null | 02 | N | ECX | 101826464 |
| 20211860 | 20128542 | 1.73 | 62.8 | null | 2020-01-19 | 2020-02-01 | null | N | null | NIVOLUMAB | 101586720 |
| 20211865 | 20128543 | 1.82 | 85.7 | Neo-adjuvant (N) | 2020-01-03 | 2020-01-05 | Panitumumab | N | N | PANITUMUMAB | 100593907 |
| 20211870 | 20128544 | 1.8 | 80 | Curative (C) | 2017-05-31 | 2017-10-02 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100018303 |
| 20211880 | 20128546 | 1.63 | 96 | null | 2019-09-27 | 2019-10-05 | null | N | N | CISPLATIN + FLUOROURACIL | 100223552 |
| 20211884 | 20128547 | 1.69 | 66.4 | Adjuvant (A) | 2016-10-31 | 2016-11-01 | null | 02 | N | NIVOLUMAB | 101523670 |
| 20211893 | 20128548 | 1.74 | 82 | null | 2020-12-26 | 2021-03-31 | NIVOLUMAB | N | null | NIVOLUMAB | 101733428 |
| 20211895 | 20128549 | 1.78 | 68.6 | Curative (C) | 2018-08-21 | 2018-08-21 | CARBOPLATIN + ETOPOSIDE | N | null | CISPLATIN + FLUOROURACIL | 100988310 |
| 20211905 | 20128550 | 1.69 | null | null | null | 2019-07-30 | null | null | null | NIVOLUMAB | 101266229 |
| 20211913 | 20128551 | 1.95 | 61.4 | null | 2017-09-05 | 2017-12-13 | null | 02 | N | ECX | 101486396 |
| 20211914 | 20128552 | 1.81 | null | null | 2018-06-07 | 2018-12-02 | null | 02 | N | PANITUMUMAB | 101601724 |
| 20211918 | 20128553 | 1.65 | 68.3 | Palliative (P) | 2017-07-21 | 2017-07-23 | Cisplatin + Fluorouracil + RT 5day | null | N | CISPLATIN + FLUOROURACIL | 101277461 |
| 20211921 | 20128554 | 1.7 | 80.4 | Neo-adjuvant (N) | 2018-06-15 | 2018-06-20 | CARBOPLATIN + ETOPOSIDE | null | null | CARBOPLATIN + ETOPOSIDE | 100758038 |
| 20211923 | 20128555 | 1.93 | 72.85 | Neo-adjuvant (N) | 2017-11-25 | 2017-12-02 | ECX | N | N | ECX | 101421338 |
| 20211938 | 20128557 | 1.63 | 94 | Neo-adjuvant (N) | null | null | Panitumumab | 2 | N | PANITUMUMAB | 101044780 |
| 20211939 | 20128558 | 1.6 | null | Neo-adjuvant (N) | 2019-11-11 | 2019-11-16 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100965422 |
| 20211944 | 20128559 | 1.81 | null | Neo-adjuvant (N) | 2019-04-22 | 2019-05-14 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101212621 |
| 20211951 | 20128560 | 1.73 | null | Adjuvant (A) | 2018-07-09 | 2018-07-27 | null | null | N | CISPLATIN + FLUOROURACIL | 101522520 |
| 20211958 | 20128561 | 1.76 | 85.1 | Adjuvant (A) | 2017-01-31 | 2017-02-01 | CISPLATIN + FLUOROURACIL | null | Y | CISPLATIN + FLUOROURACIL | 100615501 |
| 20211960 | 20128562 | 1.52 | 140 | Neo-adjuvant (N) | 2019-07-18 | 2019-07-18 | null | 2 | Y | CARBOPLATIN + ETOPOSIDE | 101749462 |
| 20211961 | 20128563 | null | 62 | Adjuvant (A) | 2017-09-18 | 2017-10-23 | Panitumumab | 2 | N | PANITUMUMAB | 100833154 |
| 20211965 | 20128564 | 1.67 | 104 | Palliative (P) | 2017-08-28 | 2017-08-28 | null | 2 | N | NIVOLUMAB | 100604903 |
| 20211966 | 20128565 | 1.81 | 68.6 | Adjuvant (A) | 2018-07-31 | 2018-08-14 | null | N | null | ECX | 101464909 |
| 20211970 | 20128566 | 1.82 | 84 | Curative (C) | 2017-09-22 | 2017-09-22 | null | 2 | N | CISPLATIN + FLUOROURACIL | 101401744 |
| 20211971 | 20128567 | 1.63 | 58 | Palliative (P) | null | 2020-05-01 | NIVOLUMAB | N | N | NIVOLUMAB | 101003326 |
| 20211978 | 20128569 | 1.6 | 82.8 | Neo-adjuvant (N) | 2019-06-07 | 2019-10-08 | ECX | 02 | null | ECX | 101061683 |
| 20211980 | 20128570 | 1.66 | 100.7 | Curative (C) | null | 2018-12-31 | null | 02 | N | PANITUMUMAB | 100698540 |
| 20211986 | 20128571 | 1.61 | 91.8 | Neo-adjuvant (N) | 2017-11-02 | 2017-12-21 | null | null | null | CARBOPLATIN + ETOPOSIDE | 101168022 |
| 20211994 | 20128572 | 1.53 | null | Palliative (P) | 2016-02-21 | 2016-03-23 | Panitumumab | 2 | N | PANITUMUMAB | 100133556 |
| 20211998 | 20128573 | null | null | Palliative (P) | 2016-12-28 | 2017-01-09 | ECX | 2 | N | ECX | 101787762 |
| 20211999 | 20128574 | 1.56 | null | Neo-adjuvant (N) | 2016-05-18 | 2016-06-02 | null | 02 | N | PANITUMUMAB | 100329653 |
| 20212019 | 20128575 | 1.62 | null | Adjuvant (A) | null | 2020-08-21 | NIVOLUMAB | null | N | NIVOLUMAB | 100883081 |
| 20212021 | 20128576 | 1.57 | 62.8 | null | 2018-03-11 | 2018-03-11 | Panitumumab | N | null | PANITUMUMAB | 101849690 |
| 20212029 | 20128577 | 1.81 | 62.8 | Adjuvant (A) | 2021-04-25 | 2021-05-13 | null | 2 | N | CARBOPLATIN + ETOPOSIDE | 100617706 |
| 20212031 | 20128578 | 1.81 | 75.6 | Palliative (P) | 2018-07-06 | 2018-07-30 | ECX | N | N | ECX | 101403759 |
| 20212051 | 20128580 | null | 79 | Curative (C) | 2016-02-02 | 2016-05-09 | null | null | N | CARBOPLATIN + ETOPOSIDE | 100847081 |
| 20212052 | 20128581 | 1.77 | 70.1 | null | null | 2018-03-28 | null | 99 | null | ECX | 101534923 |